Trump tariff threat may raise US drug costs

US President Donald Trump proposed tariffs of up to 200% on imported generic medicines, with a phased plan starting in 2026. The move targets Indian pharmaceutical companies, which supply nearly half of generic drugs used in America. Experts warn that higher costs could be passed to American patients and insurers, potentially making affordable medicines more expensive.